Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Cancer × Valproic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 10 Brain Neoplasms 8 Myelodysplastic Syndromes 7 Neoplasm Metastasis 6 Glioblastoma 6 Recurrence 5 Lymphoma 5 Glioma 5 Sarcoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia 4 Colorectal Neoplasms 4 Astrocytoma 4 Ovarian Neoplasms 3 Neoplasms 3 Lymphoma, Large B-Cell, Diffuse 3 Head and Neck Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms, Neuroepithelial 2 Nasopharyngeal Carcinoma 2 Mouth Neoplasms 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Hodgkin Disease 2 Diffuse Intrinsic Pontine Glioma 2 Central Nervous System Neoplasms 2

Interventions

Nivolumab 15 Surveys and Questionnaires 7 Ipilimumab 7 linrodostat 5 Standard of Care 5 Paclitaxel 5 Bevacizumab 5 temsirolimus 4 Sirolimus 4 Interviews as Topic 4 Gemcitabine 4 Docetaxel 4 relatlimab 3 Vorinostat 3 Pemetrexed 3 Erlotinib Hydrochloride 3 Cetuximab 3 Carboplatin 3 ARRY-334543 3 regorafenib 2 apatinib 2 abemaciclib 2 Trastuzumab 2 Sunitinib 2 Sorafenib 2 Olanzapine 2 N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide 2 Magnetic Resonance Spectroscopy 2 Everolimus 2 Dasatinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00530907 2015-01-08

Valproic Acid and Bevacizumab in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡